Edarbi

(Azilsartan medoxomil)

Edarbi

Drug updated on 1/4/2024

Dosage FormTablet (oral; 40 mg, 80 mg)
Drug ClassAngiotensin II receptor blockers
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For the treatment of hypertension, either alone or in combination with other antihypertensive agents.

Product Monograph / Prescribing Information

Document TitleYearSource
Edarbi (azilsartan medoxomil) Prescribing Information.2022Azurity Pharmaceuticals Inc., Worburn, MA

Systematic Reviews / Meta-Analyses

Clinical Practice Guidelines